Bausch Health (TSX:BHC) GF Value : C$12.39 (As of Mar. 17, 2025)

View and export this data going back to 1987. Start your Free Trial

What is Bausch Health GF Value?

As of today (2025-03-17), Bausch Health's share price is C$10.27. Bausch Health's GF Value is C$12.39. Therefore, Bausch Health's Price-to-GF-Value for today is 0.83. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Bausch Health is Modestly Undervalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

Bausch Health (TSX:BHC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

Bausch Health's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	10.27	/	12.39
	=	0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health GF Value Related Terms

Thank you for viewing the detailed overview of Bausch Health's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

BHC:USA BHC:Mexico BVF:Germany

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Executives

Seana Lynne Carson	Senior Officer
Robert Allen Spurr	Senior Officer
Joseph Gordon	Senior Officer
Steven Daniel Miller	Director
Andrew Charles Von Eschenbach	Director
Richard Urbain De Schutter	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler	Director
William Douglas Humphries	Senior Officer
John Paulson	Director
Thomas Ross Sr.	Director
Christina Ackermann	Senior Officer
Joseph Papa	Director, Senior Officer
Paul Herendeen	Senior Officer